TIK-301
TIK-301 (also known as PD-6735) is a melatonin receptor agonist with Ki values of 0.23 nM for the MT1 receptor and 0.14 nM for the MT2 receptor. It has been studied for potential use in the treatment of insomnia and other sleep disorders.
Pharmacology[edit | edit source]
TIK-301 is a melatonin receptor agonist, meaning it stimulates the activity of the melatonin receptor. It has a high affinity for both the MT1 and MT2 receptors, with Ki values of 0.23 nM and 0.14 nM respectively. These receptors are involved in the regulation of the sleep-wake cycle, and their activation by TIK-301 may help to promote sleep.
Clinical trials[edit | edit source]
TIK-301 has been studied in clinical trials for its potential use in the treatment of insomnia and other sleep disorders. However, as of 2021, it has not been approved for medical use.
See also[edit | edit source]
References[edit | edit source]
TIK-301 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD